Summit Therapeutics Inc. Financial Ratios — SMMT Stock

Profitability (GBP)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	01/31/2011	01/31/2012	01/31/2013	01/31/2014	01/31/2015	01/31/2016	01/31/2017	01/31/2018	01/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-77.94	-88.15	-161.17	-162.65	-125.27	-135.18	- -	- -	- -	-77.93	-108.89	-75.05	-601.85	-94.9	-206.1
Return on Assets (%)	-56.15	-59.69	-102.42	-106.09	-83.15	-88.37	-64.63	-45.62	13.79	-57.9	-82.09	-20.26	-141.83	-69.32	-181.94
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	- -	- -	100	99.44	99.96	100	100	100	- -	- -	- -
EBITDA Margin (%)	429.75	-159.43	-246.91	-486.04	- -	- -	-1,053.04	-189.34	20.87	-5,848.72	-4,627.97	-8,845.11	- -	- -	- -
Operating Margin (%)	429.75	-170.08	-252.04	-487.93	- -	- -	-1,055.56	-192.58	17.45	-6,081.63	-4,763.68	-9,024.26	- -	- -	- -
Incremental Operating Margin (%)	1,794.49	- -	- -	- -	324.72	- -	- -	- -	110.26	- -	- -	- -	3,562.27	- -	- -
Pretax Margin (%)	-775.36	-169.86	-251.71	-487.27	- -	- -	-1,115.76	-193.53	15.91	-6,152.33	-4,897.84	-11,174.75	- -	- -	- -
Profit Margin (%)	-614.68	-152.63	-232.91	-443.13	- -	- -	-927.56	-163.09	19.04	-6,127.56	-4,897.84	-11,174.75	- -	- -	- -
Net Income to Common Margin (%)	-614.68	-152.63	-232.91	-443.13	- -	- -	-927.56	-163.09	19.04	-6,127.56	-4,897.84	-11,174.75	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-77.94	-88.15	-161.17	-162.65	-125.27	-135.18	- -	- -	- -	-77.93	-108.89	-75.05	-601.85	-94.9	-206.1

Credit (GBP)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	01/31/2011	01/31/2012	01/31/2013	01/31/2014	01/31/2015	01/31/2016	01/31/2017	01/31/2018	01/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	2	1	- -	3	519	106	7	21
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	21	3	4	3
LT Debt	- -	- -	- -	- -	- -	- -	- -	1	1	- -	2	497	103	3	18
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	-0.05	0.11	-0.01	-0.03	-8.32	-1.2	-0.03	-0.02
Net Debt/EBITDA	-0.99	0.74	0.75	0.3	0.92	0.78	1.16	0.86	-2.96	1.32	0.86	-2.66	-0.32	0.5	0.21
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	-0.05	0.13	-0.01	-0.03	-8.15	-1.2	-0.03	-0.02
Net Debt/EBIT	-0.99	0.69	0.74	0.3	0.92	0.78	1.15	0.84	-3.54	1.27	0.83	-2.6	-0.32	0.5	0.21
EBITDA to Interest Expense	819.75	-938	- -	- -	-24.45	-77.61	-28.15	-30.12	19.22	-197.25	-345.95	-14.17	-5.38	-24.28	- -
EBITDA-CapEx/Interest Expense	789.25	-978.33	- -	- -	-24.52	-77.85	-28.25	-30.74	18.95	-198.9	-347.21	-14.31	-5.39	-24.3	- -
EBIT to Interest Expense	819.75	-1,000.67	- -	- -	-24.52	-77.79	-28.21	-30.63	16.07	-205.11	-356.1	-14.46	-5.39	-24.29	- -
Interest Expense	- -	- -	- -	- -	1	- -	1	1	1	- -	- -	4	16	9	- -
Common Equity/Total Assets	72.25	61.76	65.14	65.28	66.83	64.17	-9.29	-5.71	70.15	77.52	73.46	19.07	38.28	89.25	87.71
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.52	0.09	2.03	392.65	132.95	0.89	2.66
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-51.55	1.49	0.09	1.96	77.05	56.2	0.87	2.57
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	1.74	1.07	0.07	1.49	74.88	50.89	0.79	2.33
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	-40.8	2.36	0.59	3.34	409.59	136.56	1.86	3.17
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-68.92	2.31	0.58	3.23	80.38	57.73	1.82	3.07
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	2.33	1.66	0.45	2.45	78.11	52.28	1.66	2.78
Net Debt to Equity	-88.36	-86.28	-118.52	-42.63	-86.91	-101.39	803.38	637.75	-63.14	-83.59	-86.2	130.83	36.78	-26.97	-34.19
Net Debt/Capital (%)	-759.35	-629.09	639.96	-74.3	-663.82	7,278.57	88.93	91.51	-160.98	-491.94	-502.91	55.83	25.43	-36.02	-49.57
EBITDA	5	-4	-7	-11	-18	-30	-30	-33	12	-50	-84	-62	-89	-211	-1,094
EBITDA-CapEx	5	-5	-7	-11	-18	-30	-30	-34	12	-51	-84	-63	-89	-211	-1,095
Operating Income (Loss)	5	-5	-7	-11	-18	-30	-30	-34	10	-52	-86	-64	-89	-211	-1,094

Liquidity (GBP)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	01/31/2011	01/31/2012	01/31/2013	01/31/2014	01/31/2015	01/31/2016	01/31/2017	01/31/2018	01/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.69	1.62	2.21	1.09	3.16	5.09	2.58	0.87	2.05	3.34	2.8	8.99	9.13	9.88	9.77
Current Ratio	3.09	2.06	2.74	1.66	4.26	6.5	3.06	1.56	3.56	4.41	3.8	16.93	9.3	10.15	9.87
Quick Ratio	2.69	2	2.6	1.47	4.26	6.12	3	1.56	3	4.33	3.75	9.15	9.17	9.89	9.77
CFO/Avg Current Liab	-2.36	-1.93	-2.27	-3.52	-3.92	-4.92	1.67	-0.89	-1.41	-2.6	-3.19	-1.29	-2.59	-4.57	-5.63
Common Equity/Total Assets	72.25	61.76	65.14	65.28	66.83	64.17	-9.29	-5.71	70.15	77.52	73.46	19.07	38.28	89.25	87.71
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.52	0.09	2.03	392.65	132.95	0.89	2.66
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-51.55	1.49	0.09	1.96	77.05	56.2	0.87	2.57
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	1.74	1.07	0.07	1.49	74.88	50.89	0.79	2.33
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	-40.8	2.36	0.59	3.34	409.59	136.56	1.86	3.17
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-68.92	2.31	0.58	3.23	80.38	57.73	1.82	3.07
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	2.33	1.66	0.45	2.45	78.11	52.28	1.66	2.78
CFO/Total Liabilities	-193.91	-162.48	-208.85	-231.7	-171.11	-191.4	29.55	-24.93	-147.9	-208.77	-241.23	-7.74	-61.28	-303.57	-349.79
CFO/CapEx	-22.46	-20.01	-41.93	-124.87	-314.54	-260.33	137.97	-30.35	-214.06	-114.28	-237.21	-66.64	-599.69	-1,022.35	-491.52
Altman's Z-Score	-7.62	-19.81	-15.41	-26.31	-4.69	-2.15	-3.41	-3.77	0.87	3.06	-2.21	0.83	-0.47	130.42	57.43

Working Capital (GBP)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	01/31/2011	01/31/2012	01/31/2013	01/31/2014	01/31/2015	01/31/2016	01/31/2017	01/31/2018	01/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	20.79	44.54	37.12	56.31	- -	- -	- -	2.23	6.39	0.69	2.02	0.78	- -	- -	- -
Days Sales Outstanding	17.55	8.19	9.83	6.48	- -	- -	- -	163.7	57.11	531.15	181.09	469.32	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	0.01	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	25,457.58	133,956.44	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	-25,293.88	-133,899.33	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	163.7	57.11	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (GBP)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	01/31/2011	01/31/2012	01/31/2013	01/31/2014	01/31/2015	01/31/2016	01/31/2017	01/31/2018	01/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	77	103	142	33	284	195	742	1,439	10,524	10,079
- Cash & Cash Equivalents	5	3	5	3	17	23	35	28	35	66	72	349	71	105	225
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	2	1	- -	3	519	106	7	21
Enterprise Value	-5	-3	-5	-3	-17	54	68	116	-1	218	126	912	1,359	10,119	9,386
Total Capital	6	4	5	8	20	23	-4	-3	57	80	86	645	184	396	680
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-68.92	2.31	0.58	3.23	80.38	57.73	1.82	3.07
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	0.02	-0.97	- -	0.02	0.57	0.08	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	23.58	6.62	0.15	253.77	69.58	1,294.28	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	0.73	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	0.88	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	4.22	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	4.2	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	373	512	633	87	239	183	680	1,271	10,252	9,719
Diluted Enterprise Value	-5	-3	-5	-3	-17	350	477	607	54	173	114	850	1,306	10,154	9,515
EV per Share	- -	- -	- -	- -	- -	4.42	5.49	7.87	0.27	2.64	1.28	4.32	1.94	13.72	12.11
TTM Sales	1	3	3	2	- -	- -	3	17	57	1	2	1	- -	- -	- -
TTM EBITDA	5	-4	-7	-11	-18	-30	-30	-33	12	-50	-84	-62	-89	-211	-1,094
TTM Operating Income	5	-5	-7	-11	-18	-30	-30	-34	10	-52	-86	-64	-89	-211	-1,094
TTM Cash Flow to Firm	-4	-4	-5	-10	-16	-24	16	-20	-34	-48	-72	-37	-60	-133	-323
TTM Free Cash Flow to Firm	-4	-4	-5	-10	-16	-24	16	-19	-34	-47	-72	-37	-60	-133	-322

Multiples (GBP)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	01/31/2011	01/31/2012	01/31/2013	01/31/2014	01/31/2015	01/31/2016	01/31/2017	01/31/2018	01/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	-15.32	33.52	-31.82	-2.5	-5	-2.54	-16.6	-16.59	-72.21	-30.16
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	0.88	- -	- -	- -	- -	- -	- -
Enterprise Value	-5	-3	-5	-3	-17	54	68	116	-1	218	126	912	1,359	10,119	9,386
Low Price	- -	- -	- -	- -	- -	5.7	3	6.74	0.87	0.91	1.67	0.54	1.03	1.65	11.84
EV/Sales	- -	- -	- -	- -	- -	- -	23.58	6.62	0.15	253.77	69.58	1,294.28	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	0.73	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	8	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	-15	-14.89	-21.01	36.79	-3.3	-4.72	-3.36	-1.73	-27.22	-11.28
Price/Earnings High	- -	- -	- -	- -	- -	-20.48	-35.76	-29.37	83.2	-6.01	-9.33	-11.39	-4.83	-83.26	-19.16
Price/Earnings Low	- -	- -	- -	- -	- -	-11.74	-6.91	-15.45	6.88	-1.19	-1.74	-1.32	-1.04	-5.34	-8.2
Price/Book Value	- -	- -	- -	- -	- -	3.38	-23.58	-31.91	0.58	3.58	2.34	5.86	18.53	27.07	15.3
Price/Book Value Average	- -	- -	- -	- -	- -	3.9	-18.31	-30.21	2.68	2.61	5.33	2.28	15.47	15.91	19.17
Price/Book Value High	- -	- -	- -	- -	- -	5.32	-43.96	-42.24	6.07	4.75	10.54	7.74	43.31	48.66	32.56
Price/Book Value Low	- -	- -	- -	- -	- -	3.05	-8.5	-22.22	0.5	0.94	1.97	0.9	9.34	3.12	13.93
Price/Tangible Book Value	- -	- -	- -	- -	- -	4.55	-10.8	-4.93	0.82	4.31	2.75	5.95	18.99	27.2	15.34
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	5.25	-8.39	-4.66	3.79	3.15	6.27	2.32	15.85	15.99	19.23
Price/Tangible Book Value High	- -	- -	- -	- -	- -	7.16	-20.13	-6.52	8.57	5.72	12.38	7.85	44.39	48.89	32.66
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	4.11	-3.89	-3.43	0.71	1.14	2.31	0.91	9.58	3.14	13.97
Price/Sales	- -	- -	- -	- -	- -	- -	177.93	36.19	1.52	277.49	101.42	964.36	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	138.15	34.26	7	202.45	231.21	375.57	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	331.69	47.91	15.84	368.35	456.76	1,272.96	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	64.09	25.21	1.31	73.09	85.25	147.3	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	-15.26	33.77	-30.77	-2.48	-4.96	-2.53	-16.35	-16.56	-72.14	-30.1
Price/Cash Flow Average	- -	- -	- -	- -	- -	-17.59	26.22	-29.12	-11.39	-3.62	-5.76	-6.37	-13.83	-42.4	-37.71
Price/Cash Flow High	- -	- -	- -	- -	- -	-24	62.94	-40.72	-25.76	-6.58	-11.38	-21.58	-38.71	-129.66	-64.07
Price/Cash Flow Low	- -	- -	- -	- -	- -	-13.76	12.16	-21.43	-2.13	-1.31	-2.12	-2.5	-8.35	-8.32	-27.41
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	-17.65	26.03	-30.12	-11.5	-3.65	-5.79	-6.46	-13.85	-42.44	-37.79
Price/Free Cash Flow High	- -	- -	- -	- -	- -	-24.09	62.49	-42.11	-26.01	-6.64	-11.43	-21.91	-38.78	-129.79	-64.2
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	-13.81	12.08	-22.16	-2.15	-1.32	-2.13	-2.54	-8.37	-8.33	-27.46
EV/Sales Average	- -	- -	- -	- -	- -	- -	15.58	6.18	2.03	164.41	207.46	651.42	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	54.47	9.25	5.34	361.98	447.04	1,631.22	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	0.7	4.15	0.02	10.35	52.41	402.18	- -	- -	- -
EV/EBITDA Average	-0.99	0.74	0.75	0.3	0.92	-2.23	-1.48	-3.26	9.72	-2.81	-4.48	-7.36	-13.97	-28.86	-11.35
EV/EBITDA High	-0.99	0.74	0.75	0.3	0.92	-3.33	-5.17	-4.88	25.56	-6.19	-9.66	-18.44	-38.4	-89.23	-19.42
EV/EBITDA Low	-0.99	0.74	0.75	0.3	0.92	-1.57	-0.07	-2.19	-0.5	-0.18	-1.13	-4.55	-8.59	-5.29	-8.2
EV/EBIT Average	-0.99	0.69	0.74	0.3	0.92	-2.22	-1.48	-3.21	11.62	-2.7	-4.35	-7.22	-13.93	-28.85	-11.35
EV/EBIT High	-0.99	0.69	0.74	0.3	0.92	-3.32	-5.16	-4.8	30.57	-5.95	-9.38	-18.08	-38.31	-89.19	-19.42
EV/EBIT Low	-0.99	0.69	0.74	0.3	0.92	-1.57	-0.07	-2.15	-0.59	-0.17	-1.1	-4.46	-8.57	-5.29	-8.2
Last Price	- -	- -	- -	- -	- -	6.32	8.33	9.68	1.01	3.44	1.99	3.52	2.05	14.27	13
High Price	- -	- -	- -	- -	- -	9.94	15.52	12.81	10.55	4.57	8.95	4.64	4.8	25.64	27.67
Enterprise Value Average	-5	-3	-5	-3	-17	66	45	108	116	141	375	459	1,236	6,087	12,424
Enterprise Value High	-5	-3	-5	-3	-17	99	157	162	305	311	809	1,150	3,399	18,817	21,251
Enterprise Value Low	-5	-3	-5	-3	-17	47	2	73	-6	9	95	284	761	1,116	8,974

Shares Outstanding	34	37	4	5	8	12	12	15	32	83	98	211	702	738	775
Diluted Weighted Avg Shares	168	187	4	409	8	59	62	65	86	69	92	193	620	719	748
Basic Weighted Avg Shares	168	187	4	409	8	59	62	65	86	69	92	193	620	719	748
Revenue per Share	0.01	0.01	0.81	0.01	- -	- -	0.05	0.27	0.67	0.01	0.02	- -	- -	- -	- -
EBITDA per Share	0.03	-0.02	-2	-0.03	-2.24	-0.5	-0.49	-0.51	0.14	-0.73	-0.91	-0.32	-0.14	-0.29	-1.46
Operating Income per Share	0.03	-0.03	-2.04	-0.03	-2.24	-0.5	-0.49	-0.51	0.12	-0.75	-0.93	-0.33	-0.14	-0.29	-1.46
Basic EPS, GAAP	-0.04	-0.02	-1.88	-0.02	-2.09	-0.49	-0.43	-0.44	0.13	-0.76	-0.96	-0.41	-0.99	-0.31	-1.44
Basic EPS from Cont Ops	-0.04	-0.02	-1.88	-0.02	-2.09	-0.49	-0.43	-0.44	0.13	-0.76	-0.96	-0.41	-0.99	-0.31	-1.44
Diluted EPS, GAAP	-0.04	-0.02	-1.88	-0.02	-2.09	-0.49	-0.43	-0.44	0.13	-0.76	-0.96	-0.41	-0.99	-0.31	-1.44
Diluted EPS from Cont Ops	-0.04	-0.02	-1.88	-0.02	-2.09	-0.49	-0.43	-0.44	0.13	-0.76	-0.96	-0.41	-0.99	-0.31	-1.44
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.03	-0.02	-1.42	-0.02	-2.02	-0.41	0.25	-0.31	-0.41	-0.69	-0.79	-0.22	-0.12	-0.2	-0.43
Free Cash Flow per Basic Share	-0.03	-0.02	-1.46	-0.02	-2.02	-0.42	0.24	-0.32	-0.41	-0.7	-0.79	-0.22	-0.12	-0.2	-0.43
Cash & Equivalents per Share	0.15	0.09	1.51	0.69	2.06	1.89	2.84	1.93	1.1	0.8	0.73	1.65	0.27	0.56	0.92
Book Value per Share	0.17	0.1	1.27	1.63	2.37	1.87	-0.35	-0.3	1.74	0.96	0.85	0.6	0.11	0.53	0.85
Tangible Book Value per Share	0.12	0.05	1.2	0.21	1.62	1.39	-0.77	-1.96	1.23	0.8	0.72	0.59	0.11	0.52	0.85

Summit Therapeutics Inc.

Profitability (GBP)

Credit (GBP)

Liquidity (GBP)

Working Capital (GBP)

Enterprise Value (GBP)

Multiples (GBP)

Per Share Data Items (GBP)